MDNews - Eastern Pennsylvania/Northwest New Jersey

June/July 2015

Issue link: https://viewer.e-digitaledition.com/i/512409

Contents of this Issue

Navigation

Page 8 of 19

FO R G I N G CO M M U N IT Y PA RT N ER S H I P S THE ST. LUKE'S Epilepsy Center team partners with referring physicians in the region to help patients achieve the best possible outcomes. Depending on a referring physician's preference, epileptologists and neurosurgeons at the St. Luke's Epilepsy Center can assume responsibility for the patient's treatment or outline a recommendation that can be delivered in the community neurology or primary care setting. "A patient who has been on the same medication long term and is struggling with seizures or side effects deserves to have an evaluation," says Lizbeth de Padua, MD, Medical Director of the St. Luke's Epilepsy Center. "There are many treatment options now that, in the right hands, can definitely provide patients with a better quality of life. Some referring physicians would like us to simply perform an evaluation and provide a plan of care, whereas others prefer that we oversee treatment. We work with referring physicians in whatever capacity they request." typically undergo a variety of diagnostic imaging studies, which may include functional MRI, PET/CT scanning and Wada testing, in addition to video-EEG monitoring. Typically performed by a neuroradiologist and epileptologist, Wada testing measures language and memory functioning on each side of the brain to help determine the risks of surgical resection. During a Wada test, an angiogram is performed to measure cerebral circulation. Anesthetic is then injected via catheter to alternatively anesthetize the right and left cerebral hemispheres. While each hemisphere is anesthetized, patients are asked to perform certain cognitive tasks relating to memory and language. Results from the test allow physicians to determine whether surgical resection of the portion of the brain responsible for seizures will cause cognitive defects. Functional MRI is a noninvasive alternative to Wada testing and performs a similar function by highlighting responsible brain abnormalities and analyzing language and memory lateralization to help predict postsurgical outcomes. At the St. Luke's Epilepsy Center, a multidisciplinary team of epileptologists, neurosurgeons, neuroradiologists, psychologists, nurses, rehabilitative specialists and social workers comes together for a surgical conference once diagnostic testing is complete. During this conference, the treatment team reviews the images and results from the diagnostic studies and discusses the risks and benefits of surgery. "Because we offer a variety of services under one roof, we can easily communicate and discuss each case as a team," Dr. Falowski says. "This collaboration ensures that everyone involved in a patient's care is able give an opinion as to what option will be best for that individual patient. Essentially, every patient receives a second and third opinion without having to travel to another institution." Exploring Interventional and Surgical Options Patients with generalized intractable epilepsy may be can- didates for vagus nerve stimulation, a same-day, outpatient procedure available at t he St . Lu ke's E pi le p s y C ent er. Vagus nerve stimula- tion involves placing a wire electrode around the vagus nerve on the left side of a patient's ne c k . T h e e le c t r o d e is attached to a dev ice implanted under the skin on the left, outer side of the chest and allows physicians to modulate brain response without performing invasive surgery. When the electrode stimulates the vagus nerve, an afferent signal travels to the brain to prevent a seizure from occurring or to decrease the duration of a seizure that's already in progress. Vagus nerve stimulation is ideal if the area of seizure origin is not apparent and/or if patients cannot tolerate their medications due to side effects or whose seizures have not responded to medication management. Patients who experience auras prior to their seizures may also benefit from vagus nerve stimulation, as they can use the device to stop seizures before they start. "All seizure medications can cause side effects, such as fatigue and difficulty thinking clearly," Dr. de Padua explains. "The vagus nerve stimulator eliminates the potential for these side effects and is also an FDA-approved therapy for depression. If a patient has both epilepsy and depression, a vagus nerve stimulator can help treat both conditions." "The important thing to remember is that patients have options," Dr. Falowski says. "Through our collaborative, interdisciplinary program, we can obtain seizure freedom for many patients who didn't even realize other treatments existed." For more information about the services available at the St. Luke's Epilepsy Center, visit sluhn.org or call 1-866-ST-LUKES. ■ M D N E W S . CO M ■ MD NEWS Eastern Pennsylvania/NW New Jersey | 9

Articles in this issue

Links on this page

Archives of this issue

view archives of MDNews - Eastern Pennsylvania/Northwest New Jersey - June/July 2015